Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BYFrontiers in endocrinology

Correlation between the thyrotropin-thyroxine resistance index and insulin resistance in polycystic ovary syndrome patients with phlegm-dampness syndrome.

4 affiliations
  1. 1Heilongjiang University of Chinese Medicine, Harbin, China.
  2. 2The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
  3. 3Affiliated Hospital of Shandong University of Chinese Medicine, Jinan, China.
  4. 4Suzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.

Abstract

Introduction

Polycystic ovary syndrome (PCOS) patients classified as the phlegm-dampness syndrome typically suffer from metabolic dysfunction mainly driven by insulin resistance (IR). Indices evaluating thyroid hormone responsiveness have emerged as promising biomarkers for metabolic disease research. However, limited research has investigated the thyrotropin-thyroxine resistance index (TT4RI), a marker quantifying central pituitary thyroid sensitivity, in this distinct PCOS subgroup. This study aimed to explore the association between TT4RI and IR in PCOS patients with phlegm-dampness syndrome.Methods

We enrolled 486 PCOS patients with complete baseline data in the present study. Among them, 264 patients were diagnosed with PCOS accompanied by phlegm-dampness syndrome. The 264 patients were further subdivided into two subgroups: with IR (n=208) and without IR (n=56), and clinical indicators were compared between the two subgroups. We evenly stratified the 264 phlegm-dampness syndrome PCOS patients into three groups to perform intergroup comparisons. Spearman's correlation and multivariate linear regression analyses were used to investigate the association. ROC curves were also employed to compare the discriminatory performance of TT4RI, thyroid-stimulating hormone index(TSHI), and FT3/FT4 in identifying insulin resistance in these patients(n=264). The sole primary outcome of this study was HOMA-IR.Results

Relative to the subgroup without IR (n=56), the subgroup with IR (n=208) patients displayed significantly higher blood pressure, obesity-related anthropometric values, triglycerides (TG), fasting plasma glucose (FPG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR),free triiodothyronine (FT3), thyroid-stimulating hormone (TSH) and TT4RI (P<0.05).Patients in the high TT4RI tertile group exhibited a relatively more prominent phenotype of IR. TT4RI exhibited positive correlations with weight, body mass index (BMI), FPG, FINS, HOMA-IR, free thyroxine (FT4), and TSH (P<0.05).In the multiple linear regression model, after adjusting for age, BMI, systolic blood pressure(SBP) and SHBG, only a marginally significant association was observed between HTT4RI group and IR. ROC analysis indicates that TT4RI exhibits limited discriminatory performance for identifying IR among PCOS patients with phlegm-dampness syndrome.Conclusions

Among phlegm-dampness syndrome PCOS women, diminished central pituitary thyroid hormone sensitivity is associated with increased insulin resistance. Further prospective research is needed to confirm these findings and explore clinical relevance.

Related

  1. Prevalence and Clinical Correlates of Polycystic Ovarian Syndrome in Patients with Interstitial Cystitis/ Bladder Pain Syndrome
    Hannah Ruetten, Kaylee Ferrara, Amr El Haraki +3
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxivPMC
  2. Health utility, work productivity, and total economic burden of polycystic ovary syndrome
    Journal of the Endocrine SocietyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  3. Polycystic ovary syndrome and menopausal transition: Hormonal dynamics, phenotypic evolution, and ethnic considerations
    Danxi Lv
    Acta Obstetricia et Gynecologica ScandinavicaPeer-reviewedCC BYFull text1 citedObstetrics, gynaecology & paediatricsDOAJ
  4. PRKACA modulates endoplasmic reticulum stress-associated dysfunction in granulosa cell models relevant to polycystic ovary syndrome
    Yan Zhang, Meihuan Chen, Yuan Lin +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  5. Altered integrin αvβ3 and extracellular matrix-associated molecular profile in granulosa cells from women with polycystic ovary syndrome
    Ayşe Gülüşür, Çiğdem Karaca, Selin Kenan +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
BibTeX
@article{liu2026correlation,
  title = {{Correlation between the thyrotropin-thyroxine resistance index and insulin resistance in polycystic ovary syndrome patients with phlegm-dampness syndrome.}},
  author = {Ying Liu and Ming Zhang and Ying Wang and Xueyan Lv and Shuang Ma and Jinglu Yu and Hongying Kuang and Lihui Hou and Qingxia Song},
  journal = {Frontiers in endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1940904},
  url = {https://europepmc.org/article/MED/42857337},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Correlation between the thyrotropin-thyroxine resistance index and insulin resistance in polycystic ovary syndrome patients with phlegm-dampness syndrome.
AU  - Ying Liu
AU  - Ming Zhang
AU  - Ying Wang
AU  - Xueyan Lv
AU  - Shuang Ma
AU  - Jinglu Yu
AU  - Hongying Kuang
AU  - Lihui Hou
AU  - Qingxia Song
PY  - 2026
DA  - 2026/10/08
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1940904
UR  - https://europepmc.org/article/MED/42857337
AB  - Introduction  Polycystic ovary syndrome (PCOS) patients classified as the phlegm-dampness syndrome typically suffer from metabolic dysfunction mainly driven by insulin resistance (IR). Indices evaluating thyroid hormone responsiveness have emerged as promising biomarkers for metabolic disease research. However, limited research has investigated the thyrotropin-thyroxine resistance index (TT4RI), a marker quantifying central pituitary thyroid sensitivity, in this distinct PCOS subgroup. This study aimed to explore the association between TT4RI and IR in PCOS patients with phlegm-dampness syndrome.Methods  We enrolled 486 PCOS patients with complete baseline data in the present study. Among them, 264 patients were diagnosed with PCOS accompanied by phlegm-dampness syndrome. The 264 patients were further subdivided into two subgroups: with IR (n=208) and without IR (n=56), and clinical indicators were compared between the two subgroups. We evenly stratified the 264 phlegm-dampness syndrome PCOS patients into three groups to perform intergroup comparisons. Spearman's correlation and multivariate linear regression analyses were used to investigate the association. ROC curves were also employed to compare the discriminatory performance of TT4RI, thyroid-stimulating hormone index(TSHI), and FT3/FT4 in identifying insulin resistance in these patients(n=264). The sole primary outcome of this study was HOMA-IR.Results  Relative to the subgroup without IR (n=56), the subgroup with IR (n=208) patients displayed significantly higher blood pressure, obesity-related anthropometric values, triglycerides (TG), fasting plasma glucose (FPG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR),free triiodothyronine (FT3), thyroid-stimulating hormone (TSH) and TT4RI (P<0.05).Patients in the high TT4RI tertile group exhibited a relatively more prominent phenotype of IR. TT4RI exhibited positive correlations with weight, body mass index (BMI), FPG, FINS, HOMA-IR, free thyroxine (FT4), and TSH (P<0.05).In the multiple linear regression model, after adjusting for age, BMI, systolic blood pressure(SBP) and SHBG, only a marginally significant association was observed between HTT4RI group and IR. ROC analysis indicates that TT4RI exhibits limited discriminatory performance for identifying IR among PCOS patients with phlegm-dampness syndrome.Conclusions  Among phlegm-dampness syndrome PCOS women, diminished central pituitary thyroid hormone sensitivity is associated with increased insulin resistance. Further prospective research is needed to confirm these findings and explore clinical relevance.
SN  - 1664-2392
ER  -